Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic the world is dealing
with currently. Clinical evidences suggest that the patients are predisposed to both venous
and arterial thrombotic complications. This is because of severe inflammatory responses,
injury to endothelium and activation of platelets leading to increased coagulation.
Additionally, individuals who are already receiving antithrombotic drug therapy for various
cardiovascular diseases and complications might contract the disease in which case …